Larry L. Wood - Oct 11, 2022 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role
CVP, TAVR
Signature
Linda J. Park, Attorney-in-Fact
Stock symbol
EW
Transactions as of
Oct 11, 2022
Transactions value $
-$328,570
Form type
4
Date filed
10/11/2022, 06:22 PM
Previous filing
Sep 6, 2022
Next filing
Nov 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EW Common Stock Options Exercise $266K +7.24K +3.58% $36.75 209K Oct 11, 2022 Direct F1
transaction EW Common Stock Sale -$595K -7.24K -3.46% $82.12 202K Oct 11, 2022 Direct F1
holding EW Common Stock 496 Oct 11, 2022 401(k)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EW Employee Stock Option (Right to Acquire) Options Exercise $0 -7.24K -33.34% $0.00 14.5K Oct 11, 2022 Common Stock 7.24K $36.75 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2021.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.